Bristol-Myers Squibb Co, the maker of Excedrin painkillers, said it received a subpoena from the US Attorney in Boston over pricing and marketing of drugs covered by Medicare and Medicaid.
Last month, New York-based Bristol-Myers said it started an internal review of its sales and marketing practices to make sure they don't violate laws.
The drugmaker shared information about its probe with representatives of the US attorney, who then subpoenaed the company, according to a regulatory filing.
The internal review focuses on whether Bristol-Myers's practices comply with anti-kickback laws and pricing requirements under the Medicaid program, the drugmaker said in its filing with the US Securities and Exchange Commission.
Medicaid, which is funded by the US and states, is the government health-insurance program for the poor. Medicare is the US health-insurance program for the elderly and disabled.
Government prosecutors have been cracking down on drugmakers who failed to give the best price for a medicine to government health-insurance programs or whose marketing practices resulted in fraudulent reimbursement claims.
Bristol-Myers and other drug companies have received requests for documents from the Office of the Inspector General of the Department of Health and Human Services and several states as well as the US attorney in Boston.
The filing didn't say when the subpoena was received. The investigations could result in criminal or civil claims, according to the filing.
Shares of Bristol-Myers fell US$0.07 to US$26.02 as of 4:15pm in New York Stock Exchange composite trading.
Samantha Martin, a spokeswoman for the US attorney in Massachusetts, didn't return a call made Friday evening.
The government yesterday approved applications by Alphabet Inc’s Google to invest NT$27.08 billion (US$859.98 million) in Taiwan, the Ministry of Economic Affairs said in a statement. The Department of Investment Review approved two investments proposed by Google, with much of the funds to be used for data processing and electronic information supply services, as well as inventory procurement businesses in the semiconductor field, the ministry said. It marks the second consecutive year that Google has applied to increase its investment in Taiwan. Google plans to infuse NT$25.34 billion into Charter Investments Ltd (特許投資顧問) through its Singapore-based subsidiary Fructan Holdings Singapore Pte Ltd, and
Micron Technology Inc is a driving force pushing the US Congress to pass legislation that would put new export restrictions on equipment its Chinese competitors use to make their chips, according to people familiar with the matter. A US House of Representatives panel yesterday was to vote on the “MATCH Act,” a bill designed to close gaps in restrictions on chipmaking equipment. It would also pressure foreign companies that sell equipment to Chinese chipmaking facilities to align with export curbs on US companies like Lam Research Corp and Applied Materials Inc. The bill targets facilities operated by China’s ChangXin Memory Technologies Inc
Singapore-based ride-hailing and delivery giant Grab Holdings’ planned acquisition of Foodpanda’s Taiwan operations has yet to enter the formal review stage, as regulators await supplementary documents, the Fair Trade Commission (FTC) said yesterday. Acting FTC Chairman Chen Chih-min (陳志民) told the legislature’s Economics Committee that although Grab submitted its application on March 27, the case has not been officially accepted because required materials remain incomplete. Once the filing is finalized, the FTC would launch a formal probe into the deal, focusing on issues such as cross-shareholding and potential restrictions on market competition, Chen told lawmakers. Grab last month announced that it would acquire
SECOND-RATE: Models distilled from US products do not perform the same as the original and undo measures that ensure the systems are neutral, the US’ cable said The US Department of State has ordered a global push to bring attention to what it said are widespread efforts by Chinese companies, including artificial intelligence (AI) start-up DeepSeek (深度求索), to steal intellectual property from US AI labs, according to a diplomatic cable. The cable, dated Friday and sent to diplomatic and consular posts around the world, instructs diplomatic staff to speak to their foreign counterparts about “concerns over adversaries’ extraction and distillation of US AI models.” Distillation is the process of training smaller AI models using output from larger, more expensive ones to lower the costs of training a powerful new
RSS